VPAC2受体信号促进胰腺癌的生长和免疫抑制
Tenzin Passang1,2, Shuhua Wang1,2, Hanwen Zhang1
1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
Cancer research
|May 29, 2024
概括
胰腺癌细胞中通过VIP受体2 (VPAC2) 发出信号的血管活性肠 (VIP) 促进瘤生长和免疫逃避. 阻止VPAC2可能会提高胰腺管道腺癌 (PDAC) 的免疫疗法的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 胰腺管腺癌 (PDAC) 具有复杂的瘤微环境,有助于药物耐药性.
- 血管活性肠 (VIP) 在PDAC中过度表达,并准T细胞上的VIP受体,使PDAC对免疫疗法敏感.
研究的目的:
- 为了研究PDAC中通过VIP受体2 (VPAC2) 自克林VIP信号传递的作用.
- 为了确定VPAC2信号是否影响瘤生长,免疫逃避和对免疫治疗的反应.
主要方法:
- 在PDAC患者样本中分析VIP和VPAC2联合表达.
- 在PDAC细胞中研究了VPAC2激活对基因表达的影响 (Piwi样RNA介导的基因沉默2,TGFβ1).
- 利用PDAC的小鼠模型来评估VPAC2操纵后的瘤生长和免疫治疗反应.
主要成果:
- 在PDAC患者中,高的VIP和VPAC2联合表达与减少的无复发存活率相关.
- 在PDAC细胞中VPAC2的激活促进了克隆生长,增加了TGFβ1的表达,抑制了T细胞的功能.
- 在小鼠模型中,PDAC细胞中VPAC2的丧失减少了瘤生长,并提高了对抗PD-1免疫疗法的敏感性.
结论:
- 自克林VIP/VPAC2信号促进PDAC生长和免疫抑制.
- 在PDAC治疗中,VPAC2是潜在的治疗点.
- 向VPAC2可能会提高胰腺癌免疫疗法的疗效.
相关概念视频
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:05Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K